Blocking the interactions between PD-1/PD-L1 and VISTA using CA-170, a small molecule that antagonizes the PD-L1/PD-L2 and VISTA pathways improves the anti-tumor responses in certain tumor models and highlights their distinct and non-redundant functions in regulating the immune response to tumors (169). This evidence concerns the gene VSIR and neoplasm.